Currently, the PPAR-α genetic variants and knock out studies in cancer biology are few; however, the expanding use of next-generation DNA sequencing technologies, including chromatin immunoprecipitation followed by DNA sequencing and global DNA methylation analysis will allow the identification of epigenetic modifications that may contribute to tumor progression and oncogenesis [44]. This evidence concerns the gene PPARA and neoplasm.